Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

Our study provides the first evidence of efficacy of anti PD-1 in CA melanoma patients and supports the use of anti PD-1 therapy in pts ≤18 years, included those <12 years.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2024-09-03
DOI
https://doi.org/10.1016/j.ejca.2024.114305
Citations
17
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
4.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

Alice Indini, Paweł Teterycz, Martina Ubaldi, Mario Mandalà et al.
17 citations
European Journal of Cancer
CAR-T cell therapy research
4.80
article

Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)

Alice Indini, Paweł Teterycz, Martina Ubaldi, Mario Mandalà, Daniela Massi, Rejin Kebudi, Miranda P. Dierselhuis, Shirly Grynberg, Paolo A. Ascierto, Maria Debora De Pasquale, Ines B. Brecht, Gabriele Madonna, Hildur Helgadóttir, Alexander M.M. Eggermont, Stefano Chiaravalli, Georgina Venetia Long, Piotr Rutkowski, Ewa Bień, Susana Puig, Victoria Atkinson, Naima Benannoune, Małgorzata Krawczyk, Diana Giannarelli, Karijn P.M. Suijkerbuijk, Linda Maschke, Andrea C. Ferrari, Caroline Robert, G Pecci, Lidia Mrb Arantes
article en
17 citations

Abstract

Our study provides the first evidence of efficacy of anti PD-1 in CA melanoma patients and supports the use of anti PD-1 therapy in pts ≤18 years, included those <12 years.

European Journal of CancerVol. 211
Utrecht University (NL), University of Perugia (IT), Princess Alexandra Hospital (AU), Institut Gustave Roussy (FR), Agostino Gemelli University Polyclinic (IT), University Medical Center Utrecht (NL), Hospital de Câncer de Barretos (BR), Princess Máxima Center (NL), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), University of Tübingen (DE)
European Commission, HORIZON EUROPE Framework Programme
Openalex Percentile: Top 4%
CAR-T cell therapy research
4.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.